PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
11.91%
Growth of 11.91% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
-92.37%
Cost reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive advantage potential.
229.93%
Growth of 229.93% versus flat Healthcare gross profit. Walter Schloss would verify quality.
-32.16%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
25.44%
R&D change of 25.44% versus flat Healthcare spending. Walter Schloss would verify adequacy.
2.92%
G&A change of 2.92% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
16.45%
Marketing expense change of 16.45% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-79.47%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
7.89%
Operating expenses change of 7.89% versus flat Healthcare costs. Walter Schloss would verify control.
48.89%
Total costs change of 48.89% versus flat Healthcare costs. Walter Schloss would verify control.
32.50%
Interest expense change of 32.50% versus flat Healthcare costs. Walter Schloss would verify control.
23.54%
D&A growth exceeding 1.5x Healthcare median of 4.35%. Jim Chanos would check for overinvestment.
1096.55%
EBITDA change of 1096.55% versus flat Healthcare. Walter Schloss would verify quality.
-176.85%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-19.65%
Operating income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-6.91%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
1508.25%
Other expenses growth exceeding 1.5x Healthcare median of 0.90%. Jim Chanos would check for issues.
450.39%
Income change of 450.39% versus flat Healthcare. Walter Schloss would verify quality.
413.09%
Margin change of 413.09% versus flat Healthcare. Walter Schloss would verify quality.
317.64%
Tax expense change of 317.64% versus flat Healthcare. Walter Schloss would verify strategy.
495.53%
Income change of 495.53% versus flat Healthcare. Walter Schloss would verify quality.
453.43%
Margin change of 453.43% versus flat Healthcare. Walter Schloss would verify quality.
479.36%
EPS change of 479.36% versus flat Healthcare. Walter Schloss would verify quality.
486.45%
Diluted EPS change of 486.45% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.